Addressing Latent Tuberculosis Infection Treatment Through a Collaborative Care Model With Community Pharmacies and a Health Department.

Introduction: The objective of this study was to evaluate a novel collaborative care model using community pharmacies as additional access points for latent tuberculosis infection (LTBI) treatment for patients using combination weekly therapy with isoniazid and rifapentine (3HP) plus directly observed therapy for 12 weeks.

Methods: This prospective pilot study included adult patients diagnosed with LTBI. Patients were eligible for study participation if they spoke English or Spanish and were followed by the New Mexico Department of Health (NM DOH).

Evaluation of a pharmacist-performed tuberculosis testing initiative in New Mexico.

Objective: To report experiences of the New Mexico pharmacist tuberculosis (TB) testing program.

Setting: Community pharmacies in New Mexico interested in participating in the TB testing initiative from March 2011 to August 2013.

Practice Innovation: To expand accessibility of TB testing, New Mexico pharmacists were granted the authority to prescribe, administer, and read tuberculin skin tests (TSTs) in March 2011.